Anchiano Therapeutics
  • Home
  • About Us
    • The Company
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • Our Science
    • Pan-RAS Program
    • PDE10/β-catenin Program
  • Pipeline
    • Overview
    • Small Molecule Pan-RAS Inhibitors
    • Small Molecule PDE10/β-catenin Inhibitors
  • Investors
    • Investor Relations
    • Presentations and Events
    • Press Releases
    • SEC Company Filings
    • Selected Publications
  • Home
  • About Us
    • The Company
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • Our Science
    • Pan-RAS Program
    • PDE10/β-catenin Program
  • Pipeline
    • Overview
    • Small Molecule Pan-RAS Inhibitors
    • Small Molecule PDE10/β-catenin Inhibitors
  • Investors
    • Investor Relations
    • Presentations and Events
    • Press Releases
    • SEC Company Filings
    • Selected Publications

Form F-1/A

Anchiano Therapeutics Ltd. filed this Form F-1/A on 02/7/2019

Document Outline:

PDF F-1/A: [Amend] Registration statement for certain foreign private issuers (LINK)|

Graphics and Exhibits (LINK)

Complete text submission file (LINK)

 

 

Website Terms and Conditions of Use

View Online
Download PDF

 

 

Contact Us

Ph: 857-259-4622

Email: info@anchiano.com

Address: One Kendall Square, Building 1400E, Suite 14-105, Cambridge, MA 02139 (map)

Investor relations:
Email: info@anchiano.com

Anchiano Therapeutics © 2021